Borrelia burgdorferi are susceptible to killing by a variety of human polymorphonuclear leukocyte components.

The Journal of Infectious Diseases
Denise LusitaniRuth R Montgomery

Abstract

The killing of Borrelia burgdorferi by intact human polymorphonuclear leukocytes (PMNL) and by individual PMNL components was compared. Intact PMNL killed B. burgdorferi 6.5-fold more efficiently and 5-fold more completely when spirochetes were opsonized with specific antibodies. U-cytoplasts, which have activatable oxidase, killed opsonized B. burgdorferi with an efficiency similar to that of intact PMNL in killing unopsonized B. burgdorferi. Although B. burgdorferi were susceptible to H(2)O(2) and nitric oxide, PMNL lysates killed B. burgdorferi nearly as well as intact PMNL killed opsonized B. burgdorferi, suggesting a critical role for granule contents. B. burgdorferi were killed by the PMNL antimicrobial components elastase, LL-37, bactericidal/permeability-increasing protein, and human neutrophil peptide-1. B. burgdorferi had limited susceptibility to killing by lysozyme and were not killed by azurocidin, proteinase 3, or lactoferrin. The efficient killing of B. burgdorferi by a variety of PMNL mechanisms highlights the paradoxical persistence of spirochetes in vivo.

Citations

May 3, 2005·Nature Reviews. Microbiology·Sean E Connolly, Jorge L Benach
May 23, 2006·Infection and Immunity·Philip E StewartPatricia A Rosa
Dec 8, 2010·Infection and Immunity·Claire MarchalNathalie Boulanger
Nov 15, 2006·Infection and Immunity·Ruth R MontgomeryCharles R Brown
Oct 13, 2006·Infection and Immunity·Devin D BolzJanis J Weis
Apr 23, 2004·Infection and Immunity·Ruth R MontgomeryStephen E Malawista
Mar 23, 2006·Infection and Immunity·Ruth R MontgomeryStephen E Malawista
Jan 7, 2014·PloS One·Bryan TroxellX Frank Yang
Apr 3, 2009·The Journal of Investigative Dermatology·Claire M P MarchalNathalie M Boulanger
Dec 23, 2006·Journal of Neuroimmunology·Marie AnderssonBetty P Guo
Oct 20, 2004·Oral Microbiology and Immunology·C A BrissetteS A Lukehart
Jun 30, 2009·The British Journal of Dermatology·T GambichlerA Kreuter
Mar 16, 2016·Pharmaceuticals·Nongnuj TanphaichitrDuane Hickling
May 24, 2006·Biochimica Et Biophysica Acta·Ulrich H N DürrAyyalusamy Ramamoorthy
Dec 3, 2014·Journal of Autoimmunity·Andrea T BorchersM Eric Gershwin
Dec 14, 2006·Journal of Medical Entomology·Katerina Kýcková, Jan Kopecký
May 10, 2008·Scandinavian Journal of Rheumatology·J HytönenM K Viljanen
Jan 14, 2020·Immunological Reviews·Michelle A E BrouwerLeo A B Joosten
Nov 16, 2007·Clinical and Vaccine Immunology : CVI·Dean T NardelliRonald F Schell
Oct 31, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Catherine Menten-DedoyartBernard Couvreur
Apr 4, 2018·Proceedings of the National Academy of Sciences of the United States of America·Quentin BernardUtpal Pal
Oct 18, 2015·Experimental Dermatology·Jürgen Harder
Apr 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Qilong XuFang Ting Liang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.